Design (Testphase)
Momentum & Trend
Mike Webster: Power Trend Leader
84
Hits
July 21, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 25 hits from US
Mike Webster's ideal case — a true leading stock that's trending HEALTHY rather than overheated. Requirements: an active Power Trend (low ≥10 days above the 21-EMA, 21-EMA above a rising 50-SMA), Webby RSI under 3 ATR above the 21-EMA (so no climax/overextension yet), no more than 12% below the 52-week high (Webster: 5–10% off the high = strength), and RS rating ≥ 80. These are the stocks Webster would rate 'A/A+' through a pullback and add to on strength.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(21)
- 52-Week High / Low
- The highest or lowest price of the last 52 weeks (one trading year). "Within 10% of the 52-week high" means: the stock is trading near its yearly high - a sign of strength, since weakness looks different.
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth Minnow Street company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- ATR (Average True Range)
- The average daily range in dollars (instead of percent like the ADR), including gaps. Often used as a yardstick: "3 ATR above the 21-EMA" means the price has run three normal daily moves above its trend line - significantly extended.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EMA (Exponential Moving Average)
- Like the simple moving average, but more recent prices carry more weight - the line follows price faster. The 21-day EMA is the standard short-term trend line for momentum traders.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from -100 to +100 with a school-grade rank from A+ to F. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Relative Strength (RS Rating)
- How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- SMA / Moving Average (10-, 20-, 50-, 200-Day Line)
- The average price of the last X days, plotted as a line on the chart (Simple Moving Average). The 50-day and 200-day lines are the most closely watched: price above the line = uptrend intact. The 30-week line from the Weinstein method corresponds to the 150-day line.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
- Webby RSI
- An indicator from Mike Webster (formerly of the O'Neil team): it measures how many ATRs the day's low sits above the 21-day EMA. Under 3 ATR = healthy trend; above that begins the overextended climax zone, where Webster takes partial profits instead of adding.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA Liquidia Technologies Inc | 08/11 | +241 % | 93 9/22 | Stage 2 | B +50 | 7 of 9 | 6.8 | Drug Manufacturers - Special | Neutral | — | — | Healthcare | 77.10 $ | +114.7 % | +109.9 % | +469.7 % | −1.7 % | -3.5 % | 98 | 42 | 6.2 % | 6.4 % | 0.55 | 459.8 | 38.0 | 23.7 | 64.0 | 165.9 | — | 129.8 | 46.3 % | 91.8 % | 7.7 % | 28.2 % | 9.0 % | 1.70 | 27.0 % | +1,031.2 % | 0.0 % | 0.0 % | 2.9 | 70.2 % | 16.2 % | 1.2 (10) |
| VPG Vishay Precision Group Inc | 08/04 | +90 % | 62 6/25 | Stage 2 | C -3 | 4 of 9 | 1.9 | Scientific & Technical Instr | – | — | — | Technology | 102.50 $ | +248.5 % | +260.0 % | +412.6 % | −9.7 % | -29.4 % | 98 | 3 | 8.4 % | 9.5 % | 1.43 | — | 135.1 | 5.8 | — | — | 6.76 | 56.9 | 0.9 % | 39.2 % | 1.8 % | 1.8 % | 1.4 % | — | 73.8 % | +0.2 % | 0.0 % | 0.0 % | 10.5 | 98.4 % | 10.7 % | 1.0 (2) |
| ATROB Astronics Corp Cl B | 07/30 | +130 % | — | Stage 2 | B +20 | 6 of 9 | 0.0 | Aerospace & Defense | – | — | — | Industrials | 67.00 $ | +81.9 % | +204.6 % | +450.2 % | −9.8 % | — | 98 | 50 | 9.3 % | 6.4 % | 1.13 | 83.8 | 27.1 | — | 26.1 | — | 1.45 | 34.3 | — | 31.4 % | 5.1 % | 21.2 % | 9.0 % | 2.34 | — | +8.4 % | 0.0 % | 0.0 % | 7.9 | 11.0 % | — | — |
| COHU Cohu Inc | 07/30 | +21 % | 73 7/25 | Stage 2 | B +21 | 6 of 9 | 3.2 | Semiconductor Equipment & Ma | Sells AI | — | Technology | 51.60 $ | +176.6 % | +189.3 % | +244.7 % | −5.0 % | -10.5 % | 97 | 5 | 7.9 % | 7.4 % | 1.55 | — | 101.0 | 6.6 | 4.1 | 79.1 | 1.15 | 435.8 | -8.3 % | 43.5 % | -11.5 % | -7.0 % | -2.8 % | 0.43 | 62.3 % | +12.7 % | 0.0 % | 0.0 % | 8.6 | 109.5 % | 20.7 % | 1.2 (5) | |
| GTX Garrett Motion Inc | 07/23 | +124 % | 64 8/31 | Stage 2 | B +21 | 8 of 9 | 6.6 | Auto Parts | Uses AI | — | Consumer Cyclical | 31.30 $ | +94.9 % | +102.6 % | +248.3 % | −0.6 % | +1.9 % | 96 | 80 | 3.6 % | 4.0 % | 0.79 | 20.5 | 17.5 | 1.8 | 0.0 | 17.3 | — | 11.4 | 14.1 % | 20.3 % | 9.3 % | 0.0 % | 14.1 % | -1.88 | -32.9 % | +3.1 % | 1.0 % | 17.3 % | 2.6 | 96.1 % | 3.6 % | 1.0 (1) | |
| TWST Twist Bioscience Corp | 08/03 | +131 % | 54 5/22 | Stage 2 | D -16 | 4 of 9 | 6.0 | Diagnostics & Research | – | — | — | Healthcare | 87.50 $ | +168.0 % | +192.9 % | +158.6 % | −1.8 % | -23.3 % | 96 | 42 | 7.7 % | 7.8 % | 2.12 | — | 0.0 | 14.7 | 13.7 | — | — | -35.3 | -34.9 % | 52.1 % | -19.9 % | -18.2 % | -12.9 % | 0.21 | 67.3 % | +20.3 % | 0.0 % | 0.0 % | -0.1 | 123.8 % | 36.4 % | 1.3 (12) |
| TVTX Travere Therapeutics Inc | 08/05 | +82 % | 68 6/22 | Stage 2 | B +27 | 5 of 9 | 5.4 | Biotechnology | Uses AI | — | — | Healthcare | 55.50 $ | +46.4 % | +44.7 % | +298.1 % | −1.8 % | -1.1 % | 96 | 42 | 3.6 % | 4.6 % | 1.11 | — | 78.1 | 10.1 | 54.3 | 308.7 | — | 139.0 | -29.0 % | 56.0 % | -4.0 % | -69.4 % | -6.5 % | 3.35 | 17.8 % | +110.5 % | 0.0 % | 0.0 % | -2.7 | 113.4 % | 18.9 % | 1.1 (15) |
| AMBQ Ambiq Micro, Inc. | — | — | — | Stage 2 | C +1 | 4 of 9 | 0.0 | Semiconductors | – | — | — | Technology | 73.40 $ | +179.9 % | +175.9 % | — | −8.9 % | -15.9 % | 96 | 50 | 8.1 % | 8.7 % | — | — | 0.0 | — | 8.5 | — | — | 0.0 | -46.6 % | 42.3 % | -46.9 % | -24.5 % | -14.8 % | 0.01 | 90.6 % | -4.7 % | 0.0 % | 0.0 % | 13.4 | 64.2 % | 7.3 % | — |
| SNEX Stonex Group Inc | 08/04 | +151 % | 68 6/22 | Stage 2 | B +14 | 6 of 9 | 10.9 | Capital Markets | Neutral | — | Financial Services | 70.70 $ | +117.5 % | +77.2 % | +136.1 % | −3.3 % | -10.4 % | 95 | 87 | 6.0 % | 4.9 % | 0.66 | 24.2 | 9.8 | 0.1 | 4.0 | 1.4 | — | 11.6 | 0.5 % | 1.6 % | 0.3 % | 20.2 % | 1.1 % | 7.16 | 5.0 % | +32.5 % | 0.0 % | 0.0 % | 5.5 | 85.9 % | 6.1 % | 1.0 (2) | |
| MTRN Materion Corporation | 07/29 | +50 % | 37 4/23 | Stage 2 | B +14 | 5 of 9 | 6.1 | Other Industrial Metals & Mi | Neutral | — | Basic Materials | 242.10 $ | +113.8 % | +126.6 % | +247.6 % | −1.5 % | -10.3 % | 95 | 57 | 5.2 % | 4.9 % | 1.03 | 78.6 | 41.3 | 3.2 | 6.2 | 916.3 | 1.28 | 33.0 | 5.7 % | 16.4 % | 4.0 % | 8.3 % | 4.0 % | 0.83 | 51.0 % | +6.1 % | 0.2 % | 10.1 % | 8.4 | 97.2 % | 4.0 % | 1.3 (3) | |
| TXG 10X Genomics Inc | 08/06 | -14 % | 39 4/22 | Stage 2 | C +5 | 6 of 9 | 4.7 | Health Information Services | Uses AI | — | Healthcare | 43.20 $ | +95.4 % | +122.6 % | +220.7 % | −3.1 % | -18.0 % | 95 | 42 | 8.2 % | 7.9 % | 2.04 | — | 666.7 | 7.3 | 5.7 | 38.4 | — | 119.9 | -11.3 % | 69.7 % | -3.6 % | -3.0 % | -4.5 % | 0.10 | 80.2 % | +5.3 % | 0.0 % | 0.0 % | 6.5 | 113.8 % | 25.9 % | 1.6 (16) | |
| CLOV Clover Health Investments Corp | 08/04 | +157 % | 56 5/22 | Stage 2 | C -2 | 6 of 9 | 2.7 | Healthcare Plans | Uses AI | — | — | Healthcare | 4.50 $ | +115.3 % | +109.9 % | +84.1 % | −2.6 % | -20.3 % | 95 | 42 | 5.8 % | 6.8 % | 2.42 | — | 82.0 | 1.2 | — | 50.4 | — | -0.6 | 3.7 % | 18.4 % | -2.6 % | -16.9 % | -5.6 % | — | 48.7 % | +40.3 % | 0.0 % | 0.0 % | -5.8 | 30.0 % | 6.0 % | 1.5 (4) |
| PDFS PDF Solutions Inc | 08/06 | +13 % | 46 5/25 | Stage 2 | B +18 | 7 of 9 | 3.1 | Software - Application | – | — | — | Technology | 48.90 $ | +112.2 % | +129.4 % | +220.7 % | −0.1 % | -13.5 % | 95 | 15 | 7.3 % | 7.1 % | 1.63 | 350.1 | 70.4 | 13.3 | 9.4 | — | 4.19 | 84.1 | 10.5 % | 72.1 % | 3.1 % | 2.7 % | 3.1 % | 0.26 | 65.1 % | +22.0 % | 0.0 % | 0.0 % | 6.3 | 80.4 % | 6.8 % | 1.0 (4) |
| SNX Synnex Corporation | — | +71 % | 34 4/25 | Stage 2 | B +31 | 5 of 9 | 22.4 | Electronics & Computer Distr | Sells AI | — | Technology | 238.50 $ | +94.2 % | +77.4 % | +124.5 % | −6.4 % | +20.1 % | 94 | 86 | 4.3 % | 4.0 % | 1.43 | 19.1 | 15.7 | 0.3 | 2.5 | 17.9 | 0.98 | 10.9 | 2.7 % | 7.0 % | 1.6 % | 11.7 % | 3.3 % | 0.23 | 23.2 % | +6.9 % | 0.8 % | 11.2 % | 5.1 | 95.7 % | 2.2 % | 1.2 (11) | |
| BTSG BrightSpring Health Services, Inc. | 08/07 | — | 88 8/22 | Stage 2 | B +49 | 8 of 9 | 13.8 | Health Information Services | – | — | — | Healthcare | 70.50 $ | +78.5 % | +82.8 % | +196.9 % | −0.2 % | -3.9 % | 94 | 94 | 3.0 % | 3.3 % | 1.80 | 89.6 | 38.3 | 1.0 | 6.8 | 33.4 | — | 29.4 | 3.4 % | 12.2 % | 2.3 % | 9.2 % | 4.1 % | -4.87 | 31.9 % | +14.6 % | 0.0 % | 0.0 % | 5.5 | 101.5 % | 7.5 % | 1.1 (12) |
| ACLS Axcelis Technologies Inc | 08/04 | +1 % | 61 6/25 | Stage 2 | C +1 | 6 of 9 | 5.6 | Semiconductor Equipment & Ma | – | — | — | Technology | 131.70 $ | +112.9 % | +112.7 % | +153.9 % | −6.8 % | -6.1 % | 94 | 10 | 7.1 % | 7.1 % | 1.87 | 56.2 | 38.3 | 6.6 | 5.3 | 62.9 | 1.45 | 29.7 | 4.0 % | 43.6 % | 11.9 % | 9.7 % | 4.5 % | 0.04 | 76.0 % | -17.6 % | 0.0 % | 0.0 % | 11.9 | 110.0 % | 9.0 % | 1.8 (5) |
| OSCR Oscar Health Inc | 08/05 | +84 % | 79 7/22 | Stage 2 | B +28 | 7 of 9 | 8.2 | Healthcare Plans | Uses AI | — | — | Healthcare | 29.60 $ | +108.3 % | +97.3 % | +42.8 % | −5.6 % | -21.2 % | 94 | 87 | 5.6 % | 6.6 % | 2.34 | — | 588.2 | 0.6 | 5.3 | 2.9 | — | 0.0 | 15.2 % | 17.4 % | -0.3 % | -2.6 % | 0.1 % | 0.26 | 17.9 % | +27.5 % | 0.0 % | 0.0 % | 3.0 | 67.6 % | 7.1 % | 1.9 (7) |
| CECO CECO Environmental Corp. | 08/04 | +219 % | 36 5/29 | Stage 2 | B +35 | 5 of 9 | 3.5 | Pollution & Treatment Contro | – | — | — | Industrials | 78.90 $ | +61.5 % | +44.1 % | +230.0 % | −6.1 % | +13.8 % | 94 | 17 | 4.7 % | 6.4 % | 1.47 | 241.8 | 48.8 | 4.3 | 17.2 | 859.0 | 1.88 | 73.1 | 5.9 % | 33.7 % | 1.7 % | 5.4 % | 3.8 % | 0.09 | 30.4 % | +38.8 % | 0.0 % | 0.0 % | 5.1 | 54.8 % | 3.7 % | 1.0 (6) |
| SEPN Septerna, Inc. Common Stock | 08/10 | — | — | Stage 2 | C -4 | 4 of 9 | 0.0 | Biotechnology | – | — | — | Healthcare | 32.20 $ | +31.2 % | +17.9 % | +242.4 % | −9.1 % | +30.3 % | 94 | 50 | 7.5 % | 6.9 % | — | — | 107.5 | — | — | — | — | 0.0 | — | 100.0 % | -49.9 % | -9.3 % | -8.5 % | — | — | +4,174.5 % | 0.0 % | 0.0 % | 7.0 | 102.7 % | 11.7 % | — |
| MOV Movado Group Inc | — | +25 % | — | Stage 2 | B +27 | 8 of 9 | 0.0 | Luxury Goods | – | — | — | Consumer Cyclical | 38.40 $ | +92.4 % | +95.2 % | +167.3 % | −3.9 % | +24.7 % | 94 | 50 | 3.2 % | 4.3 % | 0.98 | 28.1 | 24.1 | — | 1.7 | — | 0.84 | 13.5 | — | 54.8 % | 4.7 % | 6.5 % | 3.2 % | 0.15 | — | +2.7 % | 4.3 % | 92.4 % | 11.5 | 91.4 % | 5.3 % | — |
| STRZ Starz Entertainment LLC | — | — | — | Stage 2 | E -64 | 4 of 9 | 0.0 | Entertainment | – | — | — | Communication Services | 27.30 $ | +143.2 % | +152.5 % | +56.3 % | −9.7 % | +15.0 % | 94 | 50 | 6.8 % | 7.1 % | — | — | 3.6 | — | — | — | — | 1.7 | — | 50.7 % | -13.2 % | -34.7 % | -0.8 % | — | — | -8.2 % | 0.0 % | 0.0 % | 1.3 | 92.3 % | 3.7 % | — |
| AVR Anteris Technologies Global Corp. Common Stock | 08/10 | — | 70 6/22 | Stage 2 | D -38 | 4 of 9 | 1.0 | Medical Instruments & Supplies | – | — | — | Healthcare | 8.20 $ | +106.0 % | +80.8 % | +173.7 % | −6.4 % | +55.2 % | 94 | 42 | 6.4 % | 6.9 % | 0.73 | — | 0.0 | 533.9 | — | — | — | 0.0 | — | 74.3 % | 0.0 % | -59.2 % | -34.0 % | — | — | -29.2 % | 0.0 % | 0.0 % | 20.7 | 66.1 % | 8.3 % | — |
| MEC Mayville Engineering Co Inc | 08/04 | +51 % | 49 6/29 | Stage 2 | D -15 | 3 of 9 | 0.9 | Metal Fabrication | – | — | — | Industrials | 29.10 $ | +82.5 % | +96.1 % | +111.8 % | −3.3 % | -4.5 % | 94 | 1 | 5.2 % | 6.5 % | 1.22 | — | 22.1 | 1.6 | 4.1 | 61.2 | — | 37.1 | — | 10.7 % | -2.9 % | -6.8 % | -0.7 % | 0.10 | — | -6.0 % | 0.0 % | 0.0 % | 4.6 | 60.8 % | 5.0 % | — |
| CRS Carpenter Technology Corporation | 07/30 | +349 % | 76 9/29 | Stage 2 | B +37 | 8 of 9 | 29.8 | Metal Fabrication | Neutral | — | Industrials | 555.10 $ | +83.8 % | +81.7 % | +122.9 % | −1.0 % | -18.4 % | 93 | 77 | 3.8 % | 4.1 % | 1.22 | 62.1 | 23.4 | 9.8 | 14.4 | 73.1 | 1.59 | 38.3 | 22.8 % | 29.7 % | 15.8 % | 24.9 % | 11.3 % | 0.38 | 56.2 % | +4.3 % | 0.1 % | 8.2 % | 10.1 | 97.9 % | 3.9 % | 1.1 (9) | |
| ALNT Allient Inc. | 08/05 | +50 % | — | Stage 2 | B +19 | 7 of 9 | 0.0 | Electronic Components | Neutral | — | Technology | 86.60 $ | +78.9 % | +77.1 % | +183.8 % | −2.3 % | -27.8 % | 93 | 50 | 6.4 % | 6.4 % | 1.59 | 68.3 | 34.1 | — | 5.4 | — | — | 23.8 | 7.3 % | 32.9 % | 4.3 % | 8.2 % | 5.1 % | 0.65 | 53.0 % | +4.6 % | 0.2 % | 5.9 % | 8.4 | 78.8 % | 5.5 % | 1.3 (3) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Mike Webster's ideal case — a true leading stock that's trending HEALTHY rather than overheated. Requirements: an active Power Trend (low ≥10 days above the 21-EMA, 21-EMA above a rising 50-SMA), Webby RSI under 3 ATR above the 21-EMA (so no climax/overextension yet), no more than 12% below the 52-week high (Webster: 5–10% off the high = strength), and RS rating ≥ 80.
All scanners are recalculated daily across the entire stock universe — most recently on 21. July 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 84 stocks pass this scanner's criteria (as of 21. July 2026). The 25 strongest hits are shown.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- 21-EMA Trend
- Above 21-EMA Pullback
- Above the 50- & 200-SMA
- Ameet Rai: Daily Liquidity
- CANSLIM Type RS
- Character Change (CC)
- Chris Perruna: Daily New Highs
- Chris Perruna: Within 15% of Highs
- Gary Antonacci: Dual Momentum (Stock Adaptation)
- High ADR (≥5%)
- Jeff Sun
- Kathy Donnelly: Liquid Movers Up
- Mark Minervini: Trend Criteria — 1 Month
- Mike Webster: Cross Fire
- Mike Webster: Down Days Tell Screen
- Mike Webster: Swing Trading List
- Near 52-Week High
- Oliver Kell: 52 Week Highs
- Oliver Kell: Doublers
- Oliver Kell: Strength on Down Day
- Power Trend
- Qullamaggie: Top Gainers 1M
- Qullamaggie: Top Gainers 3M
- Qullamaggie: Top Gainers 6M
- Qullamaggie: Trend Intensity (13/65)
- RS Leader (≥90)
- RS New Highs
- Richard Moglen: 1 Week Top Performers
- Richard Moglen: Gaps and Strong Moves
- Richard Moglen: Top Performers 3/6 Month
- Stage 2 Leader
- Stan Weinstein: Checklist
- Stan Weinstein: Stage 1
- Stan Weinstein: Stage 2
- Stan Weinstein: Stage 3
- Strength on Stress Days
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.